W2W PARTNERS INC. – Trademark Portfolio
Entity Type: 03
W2W PARTNERS INC. holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 5 filings in this category. The portfolio also extends into Class 20 (Furniture) across 4 Nice Classification classes. Currently, 3 trademarks are registered and 2 are pending. Notable registered marks include UNICORN, PLANTICATORS, and TOP THE ORGANIC PROJECT. The owner is based in DUXBURY, MA.
65 ACORN STREET
DUXBURY, MA 02332
Showing of trademarks Trademarks
Trademark Classifications
W2W PARTNERS INC.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Advertising; business management; business administration; office functions
Common metals and their alloys; metal building materials; transportable buildings of metal
Frequently Asked Questions
How many trademarks does W2W PARTNERS INC. have?
W2W PARTNERS INC. has 5 U.S. trademarks filed with the USPTO. Of these, 3 registered, 2 pending.
What trademark classes does W2W PARTNERS INC. file in?
W2W PARTNERS INC. files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 20 (Furniture), Class 35 (Advertising & Business), Class 6 (Metal Goods). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are W2W PARTNERS INC.'s most well-known trademarks?
W2W PARTNERS INC.'s registered trademark portfolio includes well-known marks such as UNICORN, PLANTICATORS, and TOP THE ORGANIC PROJECT. These are among 3 currently registered trademarks in the portfolio.
What is W2W PARTNERS INC.'s trademark registration success rate?
W2W PARTNERS INC. has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 2 applications are pending review.